Sigmatic: Here is a fact that should bother every surgery center owner and every hospital finance leader at the same time. Medicare can pay two completely different amounts for the exact same procedure, done the exact same way, depending only on which building it happens in. That gap has been there for years. What is new is how fast it is moving, and how much of your surgeons' hospital volume just became payable in your center instead. That is what we are getting into today. Sigmatic: Let's set the stage. The ambulatory surgery center market in the United States was about forty-five point three billion dollars in twenty twenty-five, and it is projected to grow at about six point one percent a year through twenty thirty-three. There are roughly six thousand four hundred Medicare-certified A S Cs operating right now. The Centers for Medicare and Medicaid Services, CMS for short, has spent years building policy around one basic idea. The CY twenty twenty-six final rule leaned into that harder than any rule in the last decade. It added five hundred sixty procedures to the A S C covered list, and two hundred seventy-one of those came straight off the inpatient only list. That is not a small adjustment. That is CMS pushing the door wide open and saying, come on in. Sigmatic: Here is what actually happened in the rule. A S C and hospital outpatient rates went up about two point six percent for centers that met quality reporting requirements. Notice the condition in that sentence, because it matters. CMS added five hundred sixty surgical procedures and thirty-five ancillary services to the covered list. Two hundred seventy-one of the surgical additions came out of the three-year phase-out of the inpatient only list, starting with musculoskeletal procedures under a new payment classification. Now, that two point six percent increase is not automatic. The A S C Quality Reporting Program cuts your annual payment update by two full percentage points if you do not meet reporting requirements. If your center is doing several million dollars in net revenue, that is real money, and it is completely avoidable. All it takes is a calendar and a person whose job it is to own the submission. The CY twenty twenty-seven rule will follow the same publication pattern, so before you finalize next year's budget, confirm the conversion factor, any further covered list additions, and the next phase of that inpatient only phase-out. We walk through the full twenty twenty-six rule procedure by procedure elsewhere, and I'll put the links in the description if you want the detail. Sigmatic: There is a second force working in the same direction, and it is called site neutral payment. The idea is simple. Pay the same rate for the same service no matter where it happens. Hospital outpatient rates are generally higher than A S C rates for the identical procedure today, and site neutrality exists specifically to close that gap. In the CY twenty twenty-six rule, CMS expanded site neutrality for drug administration services in certain off-campus hospital departments, paying them at the physician fee schedule rate instead of the higher hospital rate. Here is the part I want you to sit with. Every rule cycle narrows this gap mostly by pushing hospital rates down, not by raising A S C rates up. The hospital system across town knows this. It is a big reason hospitals want A S C capacity of their own, through joint ventures or outright acquisition. So that hospital is not a static competitor sitting still while you grow. As its outpatient margin compresses, it either builds its own A S C or starts competing on quality and convenience instead of price. The mechanics of that negotiating position matter a lot, and we go deeper on it in another piece. The links are below, I will put them in the show notes. Sigmatic: Let's put a few figures side by side, because context matters more than any single number. The twenty twenty-six payment update for quality reporters was two point six percent. Miss your reporting and you lose two full percentage points of that. Five hundred sixty procedures got added to the covered list, two hundred seventy-one from the inpatient only list, plus thirty-five ancillary services. There are about six thousand four hundred Medicare-certified A S Cs in the country, and thirty-five states plus D C still run some form of certificate of need requirement. None of those numbers predict what any single procedure pays at any single payer. Use them to frame a conversation with your board or your surgeons, not to price an actual case. But here is the number that stopped me. E B I T D A margin for centers under three million dollars in revenue averages twelve point eight percent. For centers over nine million, it is thirty-seven point three percent. Two centers can get paid the identical A S C rate for the identical procedure and land nowhere near each other on margin. The rule changes open the door. What happens after you walk through that door is cost control and scheduling discipline. That part has nothing to do with the fee schedule. Sigmatic: Not every newly covered procedure deserves a spot on your schedule, and the inpatient only phase-out is the perfect example of why. It started with musculoskeletal procedures, which sounds like great news if you run an orthopedic or spine program. But those are also the procedures where implants push supply cost up near thirty percent of revenue. A case that looks attractive sitting on the Medicare fee schedule can turn into a thin or even negative contribution margin the moment the implant invoice lands on your desk. Compare that to G I and ophthalmology, where supply cost typically runs twelve to fifteen percent of revenue. Those specialties almost never make headlines in a covered-list update, but they are often the steadier margin once you account for staffing and turnover time. The fix is the same no matter the specialty. Cost the procedure before you build a block schedule around it, not after. We cover implant and supply benchmarks by specialty in more detail elsewhere, and I'll put the links in the description. Sigmatic: Here is the practical version of everything we just covered. First, pull the twenty twenty-six covered procedures list and lay it next to your surgeons' current hospital case logs. Flag every procedure they already perform somewhere else that is now payable in your building. Second, cost each flagged procedure using real consumption data, what was actually used in the room, not what the preference card says should have been used. A procedure with a thin contribution margin does not get better just because you add volume to it. Third, confirm your A S C Quality Reporting submissions are current for the period tied to the twenty twenty-seven update, because a missed submission costs you the entire year's payment increase. And a quick note on contracting. Most commercial payers price A S C procedures as a percentage of the Medicare rate. A newly covered procedure with no existing commercial rate attached is not a payment yet, it is a negotiation, and the center walking in with its own contribution margin data has the stronger hand. If you are structured with a management company, remember that fee is commonly four to seven percent of net revenue on top of an equity stake, which is worth weighing against what your own case cost data could do for you. And if your state is one of the thirty-five plus D C with certificate of need rules, confirm those before you build the pro forma, not after. Sigmatic: The policy opens doors. Your case costing and your scheduling discipline decide what happens once you walk through them. If you want to make your A S C more profitable, book a free consultation with us at sigmatic dot A I. We will go through your own numbers and show you where the margin is. And grab our free guide, The 2027 A S C State of the Union. The links are in the show notes. Thanks for spending this time with us on The Margin. We will see you next episode.